MOUNTAIN VALLEY MD INC.

Toronto, A6 · Founded 2018 · CIK 0001769938 · Biotech · Public

Bioactive compounds and formulations for optimizing health across humans, animals, and plants

mvmd.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$18M
3 Form D · Feb 2020
80 months since last filing
Contracts
—
No federal contracts on record
Patents
10
7 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$7,707,782
Private capital raisedForm D · SEC$9,135,331
Private capital raisedForm D · SEC$1,046,717
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2517Metselex, Incorporated——
2518Radionetics Oncology—$54M
2519SIVEC BIOTECHNOLOGIES, INC.—$3.3M
2520MOUNTAIN VALLEY MD INC.—$18M
2521Botanix Pharmaceuticals Ltd.—$20M
2522Quantum Simulation Technologies, Inc.—$7.3M
2523NeXtGen Biologics, INC—$2.9M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Evan CliffordDirector
  • Christopher CrupiExecutive Officer
  • CHRIS CRUPIExecutive Officer
  • DENNIS HANCOCKDirector · Executive Officer
  • Michael MonacoDirector · Executive Officer

Patents

USPTO · 7 granted of 10

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.